Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiation resistance in a melphalan-resistant subline of a rat mammary carcinoma

Journal Article · · Radiation Research
DOI:https://doi.org/10.2307/3578669· OSTI ID:70238
A subline of a rat mammary carcinoma (MATB 13762), selected for resistance to melphalan, is cross-resistant to other alkylating drugs, to unrelated drugs and to ionizing radiation. The difference in radioresponse between the sensitive wild-type cell line and the melphalan- and radiation-resistant line (MLN{sup r}) is related to the size of the {alpha} component in the linear-quadratic model. Reduction of dose rate does not affect the response of MLN{sup r} cells but does increase survival for wild-type cells. MLN{sup r} cells have elevated levels of reduced glutathione (GSH) and overexpress redox enzymes glutathione-S-transferase and glutathione peroxidase. Modest depletion of GSH (to 50% of control) radiosensitizes MLN{sup r} cells but not wild-type cells. On the basis of the results of an excitation assay, growth delay and tumor control experiments, MATB MLN{sup r} tumors are also more radioresistant than wild-type cells when irradiated in situ. However, wild-type cells irradiated shortly after excision of the tumor are much more radioresistant than the same cells irradiated 24 h after excision or maintained in culture, and their response resembles that of MLN{sup r} cells irradiated under the same conditions. These results suggest that, in spite of some similarity between the in vivo and in vitro observations, intrinsic radioresistance is not the most important factor influencing the response of MLN{sup r} cells in vivo. 22 refs., 7 figs., 4 tabs.
Sponsoring Organization:
USDOE
OSTI ID:
70238
Journal Information:
Radiation Research, Journal Name: Radiation Research Journal Issue: 2 Vol. 139; ISSN 0033-7587; ISSN RAREAE
Country of Publication:
United States
Language:
English